Trial Outcomes & Findings for Treatment Engagement With Technology-assisted Treatment (NCT NCT02674477)

NCT ID: NCT02674477

Last Updated: 2019-08-22

Results Overview

The acceptability assessment asks about hospital satisfaction for both groups. The questionnaire is a series of questions on Qualtrics on a scale of 0-10. Higher scores signified a more positive response and a better outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

95 participants

Primary outcome timeframe

prior to discharge from the hospital up to 30 days

Results posted on

2019-08-22

Participant Flow

Participant milestones

Participant milestones
Measure
Therapeutic Education System (TES)
Participants will have the opportunity to use the TES program while hospitalized, at specific, monitored times, and can also use it when discharged by using their specific login information. They can use it as much or as little as they like. They will continue with treatment as usual during and after hospitalization, as well. Therapeutic Education System (TES): The TES program is made of modules about ways to prevent substance use, such as how to refuse drugs and alcohol, how to cope with thoughts about using, and how to make the best possible decisions for a person's mental health. Each module takes less than 30 minutes to complete. Modules may contain videos or other interactive media. At the end of each module, there are questions about the material.
Treatment as Usual (TAU)
Standard treatment comprises a psychiatrist-led interdisciplinary team as well as face-to-face group counseling for substance use and skills for improving general mental health. There will be no change to the routine care (treatment at usual \[TAU\]) provided to patients on the service. Treatment as Usual (TAU): Participants will received standard treatment during and after hospitalization.
Overall Study
STARTED
48
47
Overall Study
COMPLETED
40
45
Overall Study
NOT COMPLETED
8
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Therapeutic Education System (TES)
Participants will have the opportunity to use the TES program while hospitalized, at specific, monitored times, and can also use it when discharged by using their specific login information. They can use it as much or as little as they like. They will continue with treatment as usual during and after hospitalization, as well. Therapeutic Education System (TES): The TES program is made of modules about ways to prevent substance use, such as how to refuse drugs and alcohol, how to cope with thoughts about using, and how to make the best possible decisions for a person's mental health. Each module takes less than 30 minutes to complete. Modules may contain videos or other interactive media. At the end of each module, there are questions about the material.
Treatment as Usual (TAU)
Standard treatment comprises a psychiatrist-led interdisciplinary team as well as face-to-face group counseling for substance use and skills for improving general mental health. There will be no change to the routine care (treatment at usual \[TAU\]) provided to patients on the service. Treatment as Usual (TAU): Participants will received standard treatment during and after hospitalization.
Overall Study
Protocol Violation
8
2

Baseline Characteristics

Treatment Engagement With Technology-assisted Treatment

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Therapeutic Education System (TES)
n=48 Participants
Participants will have the opportunity to use the TES program while hospitalized, at specific, monitored times, and can also use it when discharged by using their specific login information. They can use it as much or as little as they like. They will continue with treatment as usual during and after hospitalization, as well. Therapeutic Education System (TES): The TES program is made of modules about ways to prevent substance use, such as how to refuse drugs and alcohol, how to cope with thoughts about using, and how to make the best possible decisions for a person's mental health. Each module takes less than 30 minutes to complete. Modules may contain videos or other interactive media. At the end of each module, there are questions about the material.
Treatment as Usual (TAU)
n=47 Participants
Participants will have the typical treatment during and after their hospitalizations, without additional intervention. Treatment as Usual (TAU): Participants will received standard treatment during and after hospitalization.
Total
n=95 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
48 Participants
n=5 Participants
47 Participants
n=7 Participants
95 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
38.5 years
STANDARD_DEVIATION 10.4 • n=5 Participants
39.8 years
STANDARD_DEVIATION 8.1 • n=7 Participants
39.01 years
STANDARD_DEVIATION 9.3 • n=5 Participants
Sex: Female, Male
Female
15 Participants
n=5 Participants
16 Participants
n=7 Participants
31 Participants
n=5 Participants
Sex: Female, Male
Male
33 Participants
n=5 Participants
31 Participants
n=7 Participants
64 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
3 Participants
n=7 Participants
3 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
48 Participants
n=5 Participants
44 Participants
n=7 Participants
92 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
16 Participants
n=5 Participants
18 Participants
n=7 Participants
34 Participants
n=5 Participants
Race (NIH/OMB)
White
32 Participants
n=5 Participants
27 Participants
n=7 Participants
59 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
48 Participants
n=5 Participants
47 Participants
n=7 Participants
95 Participants
n=5 Participants

PRIMARY outcome

Timeframe: prior to discharge from the hospital up to 30 days

The acceptability assessment asks about hospital satisfaction for both groups. The questionnaire is a series of questions on Qualtrics on a scale of 0-10. Higher scores signified a more positive response and a better outcome.

Outcome measures

Outcome measures
Measure
Therapeutic Education System (TES)
n=40 Participants
Participants will have the opportunity to use the TES program while hospitalized, at specific, monitored times, and can also use it when discharged by using their specific login information. They can use it as much or as little as they like. They will continue with treatment as usual during and after hospitalization, as well. Therapeutic Education System (TES): The TES program is made of modules about ways to prevent substance use, such as how to refuse drugs and alcohol, how to cope with thoughts about using, and how to make the best possible decisions for a person's mental health. Each module takes less than 30 minutes to complete. Modules may contain videos or other interactive media. At the end of each module, there are questions about the material.
Treatment as Usual (TAU)
n=45 Participants
Participants will have the typical treatment during and after their hospitalizations, without additional intervention. Treatment as Usual (TAU): Participants will received standard treatment during and after hospitalization.
Acceptability of Treatment Based on Survey Questionnaire Completed by Participants
8.78 score on a scale
Standard Error 0.2
8.23 score on a scale
Standard Error 0.3

SECONDARY outcome

Timeframe: 30 days after discharge from the hospital

Population: We only analyzed those who were referred to substance abuse treatment, and for whom we were able to receive the information from their treatment program

Outcome measures

Outcome measures
Measure
Therapeutic Education System (TES)
n=41 Participants
Participants will have the opportunity to use the TES program while hospitalized, at specific, monitored times, and can also use it when discharged by using their specific login information. They can use it as much or as little as they like. They will continue with treatment as usual during and after hospitalization, as well. Therapeutic Education System (TES): The TES program is made of modules about ways to prevent substance use, such as how to refuse drugs and alcohol, how to cope with thoughts about using, and how to make the best possible decisions for a person's mental health. Each module takes less than 30 minutes to complete. Modules may contain videos or other interactive media. At the end of each module, there are questions about the material.
Treatment as Usual (TAU)
n=35 Participants
Participants will have the typical treatment during and after their hospitalizations, without additional intervention. Treatment as Usual (TAU): Participants will received standard treatment during and after hospitalization.
Number of Participants Enrolled in Post-discharge Substance Abuse Treatment Appointments 30 Days After Hospital Discharge
23 Participants
19 Participants

SECONDARY outcome

Timeframe: 30 days after discharge from the hospital

Population: We only analyzed those who were referred to other mental health treatment, and for whom we were able to receive the information from their treatment program

Outcome measures

Outcome measures
Measure
Therapeutic Education System (TES)
n=36 Participants
Participants will have the opportunity to use the TES program while hospitalized, at specific, monitored times, and can also use it when discharged by using their specific login information. They can use it as much or as little as they like. They will continue with treatment as usual during and after hospitalization, as well. Therapeutic Education System (TES): The TES program is made of modules about ways to prevent substance use, such as how to refuse drugs and alcohol, how to cope with thoughts about using, and how to make the best possible decisions for a person's mental health. Each module takes less than 30 minutes to complete. Modules may contain videos or other interactive media. At the end of each module, there are questions about the material.
Treatment as Usual (TAU)
n=39 Participants
Participants will have the typical treatment during and after their hospitalizations, without additional intervention. Treatment as Usual (TAU): Participants will received standard treatment during and after hospitalization.
Number of Participants Enrolled in Post-discharge Treatment for Other Mental Health Appointments 30 Days After Hospital Discharge
18 Participants
22 Participants

Adverse Events

Therapeutic Education System (TES)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Treatment as Usual (TAU)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Alexis Hammond

Johns Hopkins University

Phone: 410-550-0045

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place